AtCor Medical

ATCOR develops innovative medical devices and digital solutions to help clinicians identify and reduce the risks of hypertension, cardiovascular disease (CVD), and other related vascular conditions. Using ATCOR’s SphygmoCor® technology, researchers and clinicians can collect and evaluate clinically relevant digital vascular biomarkers, aiding in better monitoring of patients' daily conditions. These biomarkers also reveal subclinical changes in the arterial system, enhancing the efficacy of treatments in clinical trials for chronic vascular diseases.